ArticleClinicoEconomics and outcomes research : CEOR2012

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package.

Thunyarat Anothaisintawee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.